review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | G A Stern | |
P2860 | cites work | Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use. | Q30451375 |
Gentamicin toxicity in the primate retina | Q30461223 | ||
Clostridium septicum panophthalmitis with systemic complications | Q33644499 | ||
Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes | Q33644651 | ||
A retrospective review of endophthalmitis due to coagulase-negative staphylococci | Q33644936 | ||
Post-traumatic and postoperative endophthalmitis: a comparison of visual outcomes | Q33645791 | ||
Management of endophthalmitis with pars plana vitrectomy | Q33651975 | ||
Factors associated with a poor visual result in endophthalmitis | Q34180519 | ||
Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic | Q34280948 | ||
Propionibacterium acnes endophthalmitis: an unusual manner of presentation | Q35683314 | ||
Propionibacterium-associated endophthalmitis after extracapsular cataract extraction. Review of reported cases | Q36191106 | ||
Use of Corticosteroids in Combination with Antimicrobial Drugs in the Treatment of Infectious Corneal Disease | Q37228593 | ||
Treatment of postcataract fibrinous membranes with tissue plasminogen activator | Q38533388 | ||
Antibacterial agents in the treatment of ocular infections | Q38681647 | ||
A new culture method for infectious endophthalmitis | Q38693680 | ||
Intravitreal drug therapy | Q38770153 | ||
Management options for Propionibacterium acnes endophthalmitis | Q39020459 | ||
Diagnosis and treatment of chronic postoperative bacterial endophthalmitis | Q39528872 | ||
Posttraumatic Bacillus cereus endophthalmitis | Q39593730 | ||
Chronic bacterial endophthalmitis | Q70343542 | ||
Use of tissue plasminogen activator in experimental hyphema | Q70347905 | ||
Intraocular fibrinolysis with recombinant human tissue plasminogen activator. Experimental treatment in a rabbit model | Q70358301 | ||
Treatment of experimental intravitreal fibrin with tissue plasminogen activator | Q70368796 | ||
Intravitreal clearance of tissue plasminogen activator in the rabbit | Q70394652 | ||
Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator | Q70398247 | ||
Tissue plasminogen activator treatment of postoperative intraocular fibrin | Q70406511 | ||
Toxicity of intravitreous miconazole | Q70446019 | ||
Aspergillus endophthalmitis in an intravenous drug user | Q70457810 | ||
Chronic anaerobic bacterial endophthalmitis in pseudophakic rabbit eyes | Q70978509 | ||
Retinal periphlebitis as an early sign of bacterial endophthalmitis | Q70989744 | ||
Results in the treatment of postoperative endophthalmitis | Q70992648 | ||
Moxalactam retinal toxicity | Q71004116 | ||
Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis | Q71258705 | ||
Posttraumatic endophthalmitis | Q71289913 | ||
Retinal toxicity of intravitreal gentamicin. An electron microscopic study | Q71326730 | ||
Endophthalmitis: current approaches | Q71465524 | ||
Management of infectious endophthalmitis | Q72077395 | ||
Intraocular management of endophthalmitis. A systematic approach | Q72084371 | ||
The clearance of intravitreal gentamicin | Q72092305 | ||
Postoperative pseudophakic bacterial endophthalmitis | Q72105696 | ||
Toxicity, efficacy, and clearance of intravitreally injected of cefazolin | Q72107164 | ||
Staphylococcus epidermidis endophthalmitis. Visual outcome following noninvasive therapy | Q72111322 | ||
Endogenous Aspergillus endophthalmitis in drug abusers | Q72135305 | ||
Study of experimental intraocular infection. I. The recoverability of organisms inoculated into ocular tissues and fluids. II. The influence of antibiotics and cortisone, alone and combined, on intraocular growth of these organisms | Q78716296 | ||
Intravitreal amphotericin B treatment of experimental fungal endophthalmitis | Q93746986 | ||
Anterior chamber paracentesis. Diagnostic value in postoperative endophthalmitis | Q93813487 | ||
Bacterial endophthalmitis after cataract extraction. II. Incidence in 36,000 consecutive operations with special reference to preoperative topical antibiotics. | Q53938883 | ||
Prophylaxis of Endophthalmitis with Topical Povidone-iodine | Q54072118 | ||
Coagulase-negative staphylococcal endophthalmitis. Increase in antimicrobial resistance. | Q54375169 | ||
Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. | Q54405848 | ||
Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin. | Q54421778 | ||
Intravitreal amphotericin B toxicity. | Q54423527 | ||
Methicillin- and gentamicin-resistant Staphylococcus epidermidis endophthalmitis after intraocular surgery. | Q54448513 | ||
A rat model of bacterial keratitis. Effect of antibiotics and corticosteroid. | Q54451096 | ||
Intraocular lenses and experimental bacterial endophthalmitis. | Q54512819 | ||
Toxicity of Intravitreal Injection of Amphotericin B | Q54538562 | ||
Intravitreal injection of vancomycin in experimental staphylococcal endophthalmitis | Q54625815 | ||
Intravitreal Injection of Methicillin for Treatment of Endophthalmitis | Q54647666 | ||
Rural endophthalmitis | Q58397289 | ||
Further Observations on the Diagnosis, Cause, and Treatment of Endophthalmitis | Q66882096 | ||
Candida endophthalmitis: report of an unusual case with isolation of the etiologic agent by vitreous biopsy | Q66897589 | ||
Retinal toxicity of recombinant tissue plasminogen activator in the rabbit | Q67270540 | ||
Tissue plasminogen activator for postvitrectomy fibrin formation | Q67284325 | ||
Recurrent postoperative endophthalmitis | Q67285655 | ||
BB-K8: A new aminoglycoside for intravitreal injection in bacterial endophthalmitis | Q67295181 | ||
In Vitro Activity of Cephalosporins against Methicillin-Resistant, Coagulase-Negative Staphylococci | Q67295607 | ||
Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis | Q67301775 | ||
Experimental aspects and their clinical application | Q67345282 | ||
Endophthalmitis caused by gram-negative organisms | Q67568630 | ||
Experimental intravitreal gentamicin | Q67823999 | ||
A Case-control Study of Risk Factors for Postoperative Endophthalmitis | Q67829522 | ||
Intraocular Safety of Ciprofloxacin | Q67908682 | ||
Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil | Q67972025 | ||
Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis | Q68049959 | ||
Delayed-onset pseudophakic endophthalmitis | Q68192444 | ||
Toxicity of intravitreal aminoglycosides in primates | Q68348888 | ||
Use of tobramycin in eradicating experimental bacterial endophthalmitis | Q68354648 | ||
Retained intraocular foreign bodies and endophthalmitis | Q68627088 | ||
Retinal toxicity of intravitreal gentamicin | Q68629119 | ||
Postoperative endophthalmitis following cataract surgery. Effects on subconjunctival antibiotics and other factrs | Q68669559 | ||
Spontaneous sterilization in experimental Staphylococcus epidermidis endophthalmitis | Q68699338 | ||
Cefazolin levels after intravitreal injection. Effects of inflammation and surgery | Q68738851 | ||
Macular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin | Q68795016 | ||
Pseudophakic endophthalmitis. Diagnosis and management | Q68797525 | ||
Comparative treatment of experimental Staphylococcus epidermidis endophthalmitis | Q68808595 | ||
Chronic Propionibacterium endophthalmitis after extracapsular cataract extraction and intraocular lens implantation | Q68810493 | ||
Microbial endophthalmitis resulting from ocular trauma | Q68821491 | ||
Exogenous bacterial endophthalmitis treated without systemic antibiotics | Q68826145 | ||
Chronic postoperative endophthalmitis associated with Propionibacterium acnes | Q68828717 | ||
Anaerobic bacterial endophthalmitis | Q68829899 | ||
Localized endophthalmitis: a newly described cause of the so-called toxic lens syndrome | Q68831265 | ||
Lincomycin by direct intravitreal injection in the treatment of experimental bacterial endophthalmitis | Q69144291 | ||
Endophthalmitis. Diagnostic cultures and visual results | Q69144427 | ||
Hematogenous Candida endophthalmitis--a complication of candidemia | Q69160272 | ||
Endogenous Fungal Endophthalmitis in a Drug Addict | Q69341295 | ||
Intraocular chloramphenicol and bacterial endophthalmitis | Q69353849 | ||
Experimental bacterial endophthalmitis following extracapsular lens extraction | Q69393506 | ||
Staphylococcus epidermidis (albus) endophthalmitis. Report of two cases after cataract extraction | Q69471430 | ||
Acute ischemic retinopathy due to gentamicin injection | Q69596134 | ||
Intravitreal amikacin in the treatment of bacterial endophthalmitis | Q69635926 | ||
Intravitreal antibiotic therapy with vancomycin and aminoglycoside. An experimental study of combination and repetitive injections | Q69662409 | ||
The treatment of postoperative endophthalmitis. Results of differing approaches to treatment | Q69735960 | ||
Efficacy of liposome-bound amphotericin B for the treatment of experimental fungal endophthalmitis in rabbits | Q69740956 | ||
Intraocular distribution of intravitreally administered amphotericin B in normal and vitrectomized eyes | Q69751288 | ||
Changing trends in intraocular lens implantation | Q69772214 | ||
Intraocular injection of gentamicin. Toxic effects of clearance | Q69783882 | ||
Retinal detachment following endophthalmitis | Q69873734 | ||
Amphotericin clearance in vitrectomized versus nonvitrectomized eyes | Q69877029 | ||
Complications of surgery in glaucoma. Early and late bacterial endophthalmitis following glaucoma filtering surgery | Q69901564 | ||
Late onset endophthalmitis associated with filtering blebs | Q69901567 | ||
Pharmacokinetic analysis of intravitreal ceftriaxone in monkeys | Q70068969 | ||
Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery | Q70125186 | ||
Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis | Q70215878 | ||
Intraocular gentamicin toxicity | Q70219373 | ||
Painless endophthalmitis after cataract surgery | Q70229080 | ||
Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections | Q70322851 | ||
Pars Plana Vitrectomy as a Primary Treatment for Acute Bacterial Endophthalmitis | Q39616780 | ||
Clinical diagnosis of endophthalmitis | Q39655635 | ||
Endophthalmitis following intraocular lens implantation: report of 30 cases and review of the literature | Q39728866 | ||
Metastatic bacterial endophthalmitis: a contemporary reappraisal | Q39753335 | ||
THE INTRA-OCULAR USE OF PENICILLIN | Q39851427 | ||
EXPERIMENTAL OBSERVATIONS ON THE INTRAVITREOUS USE OF PENICILLIN AND OTHER DRUGS. | Q39855021 | ||
Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis | Q39934061 | ||
Sterile Uveitis and Intraocular Lens Implantation | Q40024900 | ||
Quantitation of Bacterial Infection and Antibiotic Effect in the Cornea | Q40025090 | ||
Prophylactic antibiotics for ophthalmic surgery | Q40154648 | ||
Infectious endophthalmitis. Review of 36 cases. | Q40280018 | ||
Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase | Q40281412 | ||
Antibotics administration in the treatment of bacterial endophthalmitis. I. Periocular injections | Q40641293 | ||
Intravitreal amphotericin B treatment of Candida endophthamitis | Q40641601 | ||
Visual prognosis in bacterial endophthalmitis treated with intravitreal antibiotics | Q40716249 | ||
Etiology and Diagnosis of Bacterial Postoperative Endophthalmitis | Q40903275 | ||
Mycotic Endophthalmitis in Drug Abusers | Q41074607 | ||
Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy | Q41363720 | ||
Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. | Q41589974 | ||
Vitrectomy in experimental endophthalmitis: Part I-Fungal infection | Q41702607 | ||
Vitrectomy in experimental endophthalmitis: Part II--Bacterial endophthalmitis | Q41702612 | ||
Spontaneous inhibition of bacterial growth in experimental gram-negative endophthalmitis | Q41899188 | ||
Role of the posterior capsule in the prevention of postoperative bacterial endophthalmitis: experimental primate studies and clinical implications | Q41900309 | ||
Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal Injection | Q41915913 | ||
The interaction between Pseudomonas aeruginosa and the corneal epithelium. An electron microscopic study | Q42528002 | ||
Role of vitrectomy in Staphylococcus epidermidis endophthalmitis | Q42617128 | ||
Pharmacokinetics of intravitreal injection. Assessment of a gentamicin model by ocular dialysis | Q42647360 | ||
The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome | Q43613745 | ||
Endophthalmitis associated with sequestered intraocular Propionibacterium acnes | Q43716145 | ||
Toxicity of intravitreous ceftazidime in primate retina | Q43724073 | ||
The influence of aphakia and vitrectomy on experimental retinal toxicity of aminoglycoside antibiotics | Q43741970 | ||
Intravitreal ceftazidime in a rabbit model: dose- and time-dependent toxicity and pharmacokinetic analysis. | Q43965316 | ||
Value of a centralized surveillance system during a national epidemic of endophthalmitis | Q44076956 | ||
Intravitreal Injection of Cephaloridine in the Treatment of Endophthalmitis | Q44152898 | ||
The role of vitrectomy in the treatment of postoperative bacterial endophthalmitis. An experimental study | Q44242601 | ||
Endogenous Candida endophthalmitis. Report of 13 cases and 16 from the literature | Q44277097 | ||
Vitrectomy in endophthalmitis. Results of study using vitrectomy, intraocular antibiotics, or a combination of both | Q44367574 | ||
Intravitreal oxacillin in experimental staphylococcal endophthalmitis | Q44382257 | ||
The effect of corticosteroids in the treatment of experimental bacterial endophthalmitis | Q44522989 | ||
Retinal toxicity secondary to intraocular gentamicin injection | Q44530842 | ||
Gram-negative corneal ulcers in elderly aphakic eyes with extended-wear lenses | Q44560010 | ||
The problem of bacillus species infection with special emphasis on the virulence of Bacillus cereus. | Q44568878 | ||
Intravitreal injection of kanamycin in experimentally induced endophthalmitis | Q44609568 | ||
Endophthalmitis therapy: changing antibiotic sensitivity patterns and current therapeutic recommendations | Q44647392 | ||
Experimental intravitreal ketoconazole in DMSO. | Q44676901 | ||
National outcomes of cataract extraction. Endophthalmitis following inpatient surgery | Q44707941 | ||
Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution | Q44760974 | ||
The intravitreal use of carbenicillin (Geopen) for treatment od pseudomonas endophthalmitis | Q45231963 | ||
Endocapsular hypopyon: a clinical sign of localized endophthalmitis. | Q45997936 | ||
Comparative toxicity of intravitreal aminoglycoside antibiotics | Q49197654 | ||
Aspergillus endophthalmitis in a drug abuser. | Q51858475 | ||
Intravitreal ceftriaxone in a rabbit model. Dose- and time-dependent toxic effects and pharmacokinetic analysis. | Q52498422 | ||
BACTERIAL ENDOPHTHALMITIS AFTER CATARACT EXTRACTION. A STUDY OF 22 INFECTIONS IN 20,000 OPERATIONS. | Q53040303 | ||
Intraocular injection of gentamicin. Single injection therapy of experimental bacterial endophthalmitis. | Q53891409 | ||
Blood-borne Candida endophthalmitis. A clinical and pathologic study of 21 cases. | Q53918117 | ||
P304 | page(s) | 775-844 | |
P577 | publication date | 1993-01-01 | |
P1433 | published in | Transactions of the American Ophthalmological Society annual meeting | Q26842158 |
P1476 | title | Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis | |
P478 | volume | 91 |
Q35298831 | Current approach to postoperative endophthalmitis | cites work | P2860 |
Search more.